Menon Sandeep bought BCRX
April 6, 2026 · Form 4 insider transaction
Menon Sandeep bought 441,350 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
441,350
Price
$0.00
Total value
N/A
InsiderMenon Sandeep
Role—
SecurityEmp. Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 6, 2026
Filing dateApril 7, 2026
Shares owned after441,350
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.